Key result
Redo surgery for failing stentless aortic valves was associated with no intraoperative mortality, a 4% 30-day mortality rate, and a 16% 10-year operative mortality rate.
Why the study?
Data are limited on long-term outcomes in patients undergoing reoperation after the failure of a stentless aortic valve.
What are the intermediate-term outcomes and mortality rates following reoperation for failed Medtronic Freestyle stentless aortic valves?
Observational (n=24)
No
What are the intermediate-term outcomes and mortality rates following reoperation for failed Medtronic Freestyle stentless aortic valves?
Reoperation for failing stentless aortic valves can be performed with low intraoperative and 30-day mortality without routinely requiring root-replacement techniques.
May support reoperation feasibility after stentless aortic valve failure; hypothesis-generating in small retrospective cohort and requires prospective validation.
Background: Data are limited on long-term outcomes in patients who have undergone a reoperation following failure of a stentless aortic valve. Methods: Between 2006 and 2016, a retrospective analysis was performed on 24 patients who underwent open aortic valve replacement surgery for a failed stentless aortic valve prosthesis at Health Sciences North, Sudbury, Ontario, Canada. The primary outcome was a low mortality rate from cardiac-related deaths after 5 years. Results: All patients underwent insertion of a Medtronic Freestyle bioprosthesis (Minneapolis, MN) implanted using the modified subcoronary technique for their initial operation. The interval from the first operation to the stentless redo surgery ranged from 6 to 13 years. Aortic valve reoperation was performed for structural valve deterioration in 96% (n = 23) of the cases. Reoperations involved a removal of the stented valve leaflets and standard aortic valve replacement within the stentless casing in 20% (n = 5) of the cases, with the remaining cases requiring complete removal of the stentless prosthesis and aortic valve replacement. In those in whom a complete removal of the stentless valve was possible (n = 19), no disruption of the native aortic root occurred, with a 0% rate of conversion to a Bentall procedure. No intraoperative mortality occurred. The 30-day and 10-year operative mortality rates were 4% and 16%, respectively. Conclusions: Redo surgery for failing stentless valves can be done with relatively low risk and with acceptable long-term outcomes without resorting to root-replacement techniques.
No takes yet. Share an insight, caveat, or question.
Bittira et al. (2023) conducted an observational in Failed stentless aortic valve prosthesis (n=24). Open aortic valve replacement surgery (redo surgery) was evaluated on Mortality rate from cardiac-related deaths after 5 years. Redo surgery for failing stentless aortic valves was associated with no intraoperative mortality, a 4% 30-day mortality rate, and a 16% 10-year operative mortality rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: